The ethics of direct-to-consumer genetic testing
By Laurie Udesky,
The Lancet
| 10. 23. 2010
A report into a 1-year investigation of genetic testing firms selling directly to consumers by the US General Accounting Office (GAO) concluded in July that test results were “misleading, and of little or no practical use”. As a result of the investigation, the US Food and Drug Administration is in the process of tightening regulations for firms that sell home genetic testing kits.
On their websites the direct-to-consumer genetic firms look authoritative: they encourage customers to consult their doctors or seek genetic counselling before and after results, ask customers to sign informed consent forms, and provide information on the ostensible scientific validity of the results they provide. But the GAO report describes how 15 companies responded to inquiries from five undercover consumers who had submitted their DNA samples for testing. GAO investigators found “egregious examples” of deceptive marketing, in addition to poor or non-existent advice from supposed consultation experts. The report also raised concerns about privacy: what happens to your DNA once you send it to a private company? All these issues raise ethical concerns about providing genetic testing directly...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...